A new report looks at hiring trends © 2025 American City Business Journals. All rights reserved. Use of and/or registration ...

The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...

"EQUIP-A-Pharma is about point-of-need manufacturing—hospitals, military bases, disaster zones—ensuring rapid drug ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

Here’s how a drug gets from an idea into patients’ hands – and why Australians sometimes wait longer to access a new drug ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

We appreciate the responses to our Article,1 which suggest that the health cost of paying for new pharmaceuticals in the National Health Service (NHS), estimated at £1·25 million quality-adjusted life ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

New drugs, such as GLP-1 agonists like semaglutide, have emerged as effective treatments. However, alternatives or complementary treatments could further improve results and reduce side effects.

The new Denver Permitting Office aims to complete every permit submittal within 180 days, with a new appeal process now in place.

While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers about the FDA's new national priority voucher program, experts told ...